This is in accordance with the previously proposed role of synaptic A2AR in the adaptive processes of glutamatergic excitotoxicity aggravating striatal dopamine loss and the emergence of motor symptoms in established PD (reviewed in [53]). Here, ADORA2A is linked to Parkinson disease.